GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » Total Liabilities

ASEP Medical Holdings (ASEP Medical Holdings) Total Liabilities : $2.57 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings Total Liabilities?

ASEP Medical Holdings's Total Liabilities for the quarter that ended in Mar. 2024 was $2.57 Mil.

ASEP Medical Holdings's quarterly Total Liabilities increased from Sep. 2023 ($0.48 Mil) to Dec. 2023 ($2.28 Mil) and increased from Dec. 2023 ($2.28 Mil) to Mar. 2024 ($2.57 Mil).

ASEP Medical Holdings's annual Total Liabilities increased from Dec. 2021 ($0.11 Mil) to Dec. 2022 ($0.39 Mil) and increased from Dec. 2022 ($0.39 Mil) to Dec. 2023 ($2.28 Mil).


ASEP Medical Holdings Total Liabilities Historical Data

The historical data trend for ASEP Medical Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings Total Liabilities Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
Total Liabilities
0.11 0.39 2.28

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.57 0.48 2.28 2.57

ASEP Medical Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ASEP Medical Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.742+(0+0.00099999999999989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.532+0)
=2.28

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=19.091-16.816
=2.28

ASEP Medical Holdings's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.051+(0+-0.00099999999999989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.519+0)
=2.57

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=18.641-16.07
=2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ASEP Medical Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Traded in Other Exchanges
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.